DT
LFCR icon

DBA Trading’s Lifecore Biomedical LFCR Stock Holding History

DBA Trading’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Hold
75,000
– – 0.14% 31
2026
Q1 		$279K Hold
75,000
– – 0.14% 31
2025
Q4 		$614K Buy
+75,000
New +$555K 0.39% 27

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

DBA Trading's LFCR Position: Q2 2026 in Review

DBA Trading held its Lifecore Biomedical (LFCR) position steady in Q2 2026 at 75,000 shares worth $279K. The position accounts for 0.14% of the portfolio, ranked #31.

DBA Trading first reported a position in LFCR in Q4 2025 and has held it in 3 quarters since. The position peaked at $614K in Q4 2025. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • DBA Trading held 75,000 shares of Lifecore Biomedical worth $279K as of Q2 2026.
  • DBA Trading left its Lifecore Biomedical share count unchanged in Q2 2026.
  • Lifecore Biomedical made up 0.14% of DBA Trading's portfolio in Q2 2026, its #31 holding.
  • DBA Trading first reported a position in Lifecore Biomedical in Q4 2025 and has held it in 3 quarters since.
  • DBA Trading's Lifecore Biomedical position peaked at $614K in Q4 2025.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on DBA Trading's 13F filing for Q2 2026, filed 20 Jul 2026.